OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 31 filers reported holding OPIANT PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $56,825 | +255.2% | 2,802 | +93.8% | 0.00% | – |
| Q3 2022 | $16,000 | +14.3% | 1,446 | +22.5% | 0.00% | – |
| Q2 2022 | $14,000 | -36.4% | 1,180 | +15.5% | 0.00% | – |
| Q1 2022 | $22,000 | +120.0% | 1,022 | +235.1% | 0.00% | – |
| Q4 2021 | $10,000 | -9.1% | 305 | -30.4% | 0.00% | – |
| Q3 2021 | $11,000 | -31.2% | 438 | -63.3% | 0.00% | – |
| Q2 2021 | $16,000 | 0.0% | 1,195 | -38.5% | 0.00% | – |
| Q4 2020 | $16,000 | +23.1% | 1,943 | +12.8% | 0.00% | – |
| Q3 2020 | $13,000 | -7.1% | 1,722 | +78.6% | 0.00% | – |
| Q4 2019 | $14,000 | -53.3% | 964 | -56.9% | 0.00% | – |
| Q1 2019 | $30,000 | +36.4% | 2,235 | +44.6% | 0.00% | – |
| Q4 2018 | $22,000 | -66.2% | 1,546 | -57.2% | 0.00% | – |
| Q3 2018 | $65,000 | +132.1% | 3,615 | +82.2% | 0.00% | – |
| Q2 2018 | $28,000 | -62.7% | 1,984 | -49.1% | 0.00% | – |
| Q1 2018 | $75,000 | +158.6% | 3,900 | +200.9% | 0.00% | – |
| Q4 2017 | $29,000 | +262.5% | 1,296 | +494.5% | 0.00% | – |
| Q3 2017 | $8,000 | – | 218 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 210,000 | $2,518,000 | 5.80% |
| APIS CAPITAL ADVISORS, LLC | 196,000 | $2,350,000 | 2.65% |
| Stonepine Capital Management, LLC | 152,278 | $1,826,000 | 0.85% |
| Parkman Healthcare Partners LLC | 75,632 | $907,000 | 0.33% |
| PERRITT CAPITAL MANAGEMENT INC | 30,500 | $366,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 50,405 | $604,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 126,978 | $1,523,000 | 0.01% |
| Trexquant Investment LP | 12,219 | $147,000 | 0.01% |
| Renaissance Technologies | 193,415 | $2,319,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 74,400 | $892,000 | 0.00% |